Aerami Therapeutics
Durham
About Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $133.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2022)
- Website: aerami.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Diabetes, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aerami-therapeutics-42933 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.